Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CDK4/6 dual inhibitor abemaciclib demonstrates compelling preclinical activity against esophageal adenocarcinoma: a novel therapeutic option for a deadly disease.
Kosovec JE, Zaidi AH, Omstead AN, Matsui D, Biedka MJ, Cox EJ, Campbell PT, Biederman RWW, Kelly RJ, Jobe BA. Kosovec JE, et al. Among authors: matsui d. Oncotarget. 2017 Nov 1;8(59):100421-100432. doi: 10.18632/oncotarget.22244. eCollection 2017 Nov 21. Oncotarget. 2017. PMID: 29245989 Free PMC article.
Sep70/Pepsin expression in hypopharynx combined with hypopharyngeal multichannel intraluminal impedance increases diagnostic sensitivity of laryngopharyngeal reflux.
Hoppo T, Zaidi AH, Matsui D, Martin SA, Komatsu Y, Lloyd EJ, Kosovec JE, Civitarese AA, Boyd NH, Shetty A, Omstead AN, Smith E, Jobe BA. Hoppo T, et al. Among authors: matsui d. Surg Endosc. 2018 May;32(5):2434-2441. doi: 10.1007/s00464-017-5943-9. Epub 2017 Dec 20. Surg Endosc. 2018. PMID: 29264754
Serial Endoscopic Evaluation of Esophageal Disease in a Cancer Model: A Paradigm Shift for Esophageal Adenocarcinoma (EAC) Drug Discovery and Development.
Omstead AN, Kosovec JE, Matsui D, Martin SA, Smith MA, Aaron Guel D, Kolano J, Komatsu Y, Habib F, Lai C, Christopher K, Kelly RJ, Zaidi AH, Jobe BA. Omstead AN, et al. Among authors: matsui d. Cancer Invest. 2018;36(7):363-370. doi: 10.1080/07357907.2018.1499029. Epub 2018 Aug 24. Cancer Invest. 2018. PMID: 30142016
Preventive effect of oral hangeshashinto (TJ-14) on the development of reflux-induced esophageal cancer.
Miyashita T, Kono T, Matsui D, Yamazaki Y, Sadatomi D, Fujitsuka N, Nakanuma S, Okamoto K, Makino I, Kinoshita J, Nakamura K, Oyama K, Tajima H, Takamura H, Ninomiya I, Fushida S, Mukaisho K, Harmon JW, Ohta T. Miyashita T, et al. Among authors: matsui d. Surgery. 2018 Mar 22:S0039-6060(18)30037-0. doi: 10.1016/j.surg.2018.02.003. Online ahead of print. Surgery. 2018. PMID: 29576309 Free article.
238 results